Piascledine 300mg box of 30 capsules

Symptomatic treatment ofosteoarthritis.

Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.

Injection treatment of mild to moderate osteoarthritis of the knee or hip.
DUROLANE® has also been approved for the symptomatic treatment associated with mild to moderate osteoarthritis pain of the ankles, shoulders, elbows, wrists, fingers and toes.

Pain relief improves joint function and helps restore quality of life.

COXARTHRUM is indicated to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid of the arthritic joint.

COXARTHRUM exerts its therapeutic effect by viscosupplementation, a process by which the physiological and rheological properties of the synovial fluid of the arthritic hip are improved.

COXARTHRUM is indicated for the symptomatic treatment of coxarthrosis by intra-articular injection. COXARTHRUM must be administered only intra-articularly under radio-guidance or by ultrasound and this by a specialist doctor, to relieve the pain associated with osteoarthritis of the hip.

Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.

Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.

1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid

Indication: Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy related to joint alterations

Flector effigel is a medicine containing an anti-inflammatory and an analgesic, it is used in the short term local treatment, in adults and children over 15 years old, in case of benign trauma: sprain, strain, or contusion.

OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.

Delayed-effect symptomatic treatment of osteoarthritis of the hip and knee.

Oral gel 1200 mg: Sachets, box of 30.

Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.

Indicated in the symptomatic treatment of osteoarthritis.

Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.

SYNOVIUM HCS viscoelastic devices are indicated for the symptomatic treatment of gonarthrosis, in particular to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid in arthritic joints.

The therapeutic indications are all types of painful gonarthrosis:

- Primary gonarthrosis (Kelgreen radiological stages I, II and III)

- Gonarthrosis and associated general factors:

- Ineffectiveness of usual treatments.

- Intolerance and/or contraindication to NSAIDs and/or analgesics.

- Taking anticoagulants, poly-medication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems).

- Contraindications related to the fitting of a prosthesis: young patients and various contraindications related to the patient's condition.

- Early gonarthrosis in young patients.

- Gonarthrosis secondary to trauma and the aftermath of articular fractures.

Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.

Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee